FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/104086 [Registered on: 17/02/2026] Trial Registered Prospectively
Last Modified On: 16/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Easy to Use Herbal Tablet Sitz Bath Reduces Pain after Anorectal Surgery 
Scientific Title of Study   A Randomised Controlled Clinical Trial To Evaluate The Efficacy Of Panchvalkal Dispersible Tablet As A Substitute To Traditional Panchvalkal Kwath Avagah Sweda For The Symptomatic Relief Of Pain In Post– Operative Anorectal Cases 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Amit Tarachand Yadav 
Designation  PG Scholar 
Affiliation  Parul Institute of Ayurved 
Address  Department of PG And Ph.D. Studies in Shalya Tantra,Parul Institute of Ayurved,Parul University,P.O.Limda,Taluka Waghodia

Vadodara
GUJARAT
391760
India 
Phone  9594595514  
Fax    
Email  ay673507@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Parikshit Shirode 
Designation  Professor 
Affiliation  Parul Institute of Ayurved 
Address  Department of PG And Ph.D. Studies in Shalya Tantra,Parul Institute of Ayurved,Parul University,P.O.Limda,Taluka Waghodia

Vadodara
GUJARAT
391760
India 
Phone  9175882746  
Fax    
Email  parikshit.shirode260038@paruluniversity.com  
 
Details of Contact Person
Public Query
 
Name  Dr Amit Tarachand Yadav 
Designation  PG Scholar 
Affiliation  Parul Institute of Ayurved 
Address  Department of PG And Ph.D. Studies in Shalya Tantra,Parul Institute of Ayurved,Parul University,P.O.Limda,Taluka Waghodia

Vadodara
GUJARAT
391760
India 
Phone  9594595514  
Fax    
Email  ay673507@gmail.com  
 
Source of Monetary or Material Support  
Parul Institute of Ayurved Parul University P.O. Limda Taluka Waghodia District Vadodara State Gujarat Country India Pin code 391760 
 
Primary Sponsor  
Name  Parul Institute of Ayurved 
Address  Department of PG And Ph.D. Studies in Shalya Tantra,Parul Institute of Ayurved,Parul University,P.O.Limda,Taluka Waghodia,District Vadodara,Gujarat 391760 India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL  
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Amit Tarachand Yadav  Parul Institute of Ayurved  OPD and IPD Wards of Department of PG And Ph.D. Studies in Shalya Tantra,Parul Institute of Ayurved,Parul University,P.O.Limda,Taluka Waghodia,District Vadodara,Gujarat 391760 India
Vadodara
GUJARAT 
9594595514

ay673507@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTE PARUL INSTITUTE OF AYURVED PARUL UNIVERSITY  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:R52||Pain, unspecified. Ayurveda Condition: SULAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Panchavalkal Dispersible Tablet, Reference: anubhuta, Route: Topical, Dosage Form: Kwatha/ Kashaya, Dose: 4(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: To develop a Panchavalkal Dispersible Tablet—a convenient tablet that easily dissolves in warm water to make the same medicated sitz bath instantly.The main goal is to check whether the tablet works as well as or better than the traditional Kwath in reducing post-operative pain and discomfort
2Comparator ArmProcedure-avagAhasvedaH, अवगाहस्वेदः (Procedure Reference: Charak Sutrasthan 14/34, Procedure details: Avagah Sweda will be given with the help of Panchvakal Kwath & Patient is advised to sit in lukewarm water mix with Panchvakal Kwath)
(1) Medicine Name: Panchvakal Kwath, Reference: Bhavprakash Nighantu Vataadivarga, Route: Topical, Dosage Form: Kwatha/Kashaya, Dose: 30(g), Frequency: bd, Duration: 7 Days
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Patient undergone for Anorectal surgeries by Local and Spinal Anaesthesia , who are presenting with post-operative discomfort related to these conditions , irrespective of their Gender, Race, and Occupation .
Patients who are above 18 years and below 70 years of age .

 
 
ExclusionCriteria 
Details  Patients with uncontrolled Diabetes-Mellitus and Hypertension .
Patients not giving consent for enrollment in the study .
Patients having Malignant conditions like Carcinoma of Rectum and Anal Canal
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1. Reduction in post-operative anorectal pain (VAS score).
2. Faster pain relief compared to traditional Panchavalkal Kwatha Avagah Sweda. 
7 Days 
 
Secondary Outcome  
Outcome  TimePoints 
1. Decrease in burning sensation, swelling, tenderness, and itching.
2. Reduced recurrence of pain during follow-up.
3. Improved patient comfort and treatment compliance. 
7 Days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   02/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   After anorectal surgeries like piles (hemorrhoids), fissure, or fistula operations, patients commonly experience pain, burning, swelling, and discomfort around the anal region. Managing this pain is very important because it affects daily activities, sleep, and overall recovery. In Ayurveda, one effective method for reducing such pain is Avagaha Sweda, also known as a medicated sitz bath. Traditionally, this procedure uses Panchavalkal Kwath, a herbal decoction made by boiling the bark of five specific trees. This mixture has natural pain-relieving, wound-healing, and anti-inflammatory properties. However, preparing this Kwath takes a lot of time, effort. Patients today often have busy schedules, limited resources, and less patience to prepare such decoctions twice a day. To solve this problem, this study aims to develop a Panchavalkal Dispersible Tablet—a convenient tablet that easily dissolves in warm water to make the same medicated sitz bath instantly. This saves time, avoids the need for boiling, ensures accurate dosage, prevents contamination, and is easier to carry and use at home. The research will involve 40 patients who have undergone anorectal surgery. They will be divided into two groups: Group A: Will use the new Panchavalkal Dispersible Tablet for sitz bath. Group B: Will use the traditional Panchavalkal Kwath. Both groups will follow the treatment for 7 days, and their pain, swelling, burning, itching, and tenderness will be regularly measured using simple scoring systems like the Visual Analogue Scale (VAS). The main goal is to check whether the tablet works as well as or better than the traditional Kwath in reducing post-operative pain and discomfort. If successful, this innovation can make post-surgery care much easier and more effective for patients, improving recovery and comfort while reducing time and effort. 
Close